We are live on
!
Find out more
ASC
Atalanta Sosnoff Capital Portfolio holdings
AUM
$5.68B
1-Year Est. Return
54.21%
This Fund
S&P 500
This Quarter
Est. Return
+2.45%
1 Year Est. Return
+54.21%
3 Year Est. Return
+205.88%
5 Year Est. Return
+308.89%
10 Year Est. Return
+1,480.72%
AUM
$3.75B
AUM Growth
-$299M
(-7.4%)
Cap. Flow
-$320M
Cap. Flow
% of AUM
-8.54%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
109
New
13
Increased
32
Reduced
50
Closed
8
Avg Time Held
4.6
quarters
Top 10 Avg Time Held
2
quarters
Top 20 Avg Time Held
2.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$46M |
| 2 |
Boston Scientific
BSX
|
+$44.6M |
| 3 |
Cisco
CSCO
|
+$40.5M |
| 4 |
ConocoPhillips
COP
|
+$36.2M |
| 5 |
Adobe
ADBE
|
+$36.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$78.6M |
| 2 |
Macy's
M
|
+$58.8M |
| 3 |
Capital One
COF
|
+$51.8M |
| 4 |
Allstate
ALL
|
+$50.3M |
| 5 |
Ralph Lauren
RL
|
+$41.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.97% |
| 2 | Financials | 17.23% |
| 3 | Communication Services | 16.76% |
| 4 | Technology | 14.62% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
American Tower
AMT
$75.6B
| $66.5M | 1.77% |
706,096
-60,782
| -8% | -$5.91M |
2013 Q2
7 quarters
|
|
27
TJX Companies
TJX
$148B
| $64.4M | 1.72% |
1,839,474
-99,624
| -5% | -$3.39M |
2014 Q4
1 quarter
|
|
28
Kinder Morgan
KMI
$69.9B
| $62.2M | 1.66% |
1,477,889
-102,214
| -6% | -$4.23M |
2014 Q3
2 quarters
|
|
29
Morgan Stanley
MS
$299B
| $61.1M | 1.63% |
1,711,539
-779,164
| -31% | -$28M |
2014 Q2
3 quarters
|
|
30
Mastercard
MA
$495B
| $60.3M | 1.61% |
698,291
-36,639
| -5% | -$3.18M |
2013 Q2
7 quarters
|
|
31
Alibaba
BABA
$276B
| $59.7M | 1.59% |
716,918
+66,774
| +10% | +$6.03M |
2014 Q4
1 quarter
|
|
32
Biogen
BIIB
$33B
| $58.1M | 1.55% |
137,605
-19,339
| -12% | -$7.62M |
2013 Q2
7 quarters
|
|
|
TFCFA
33
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $53.1M | 1.42% |
1,570,052
-84,718
| -5% | -$2.94M |
2013 Q3
6 quarters
|
|
34
Merck
MRK
$344B
| $51.3M | 1.37% |
934,904
-46,288
| -5% | -$2.62M |
2013 Q4
5 quarters
|
|
|
35
Boston Scientific
BSX
$61.4B
| $50M | 1.33% |
+2,819,545
| New | +$44.6M |
2015 Q1
0 quarters
|
|
|
CELG
36
DELISTED
Celgene Corp
CELG
| $50M | 1.33% |
433,791
+143,818
| +50% | +$17.2M |
2013 Q2
7 quarters
|
|
37
SLB Ltd
SLB
$74.6B
| $43.9M | 1.17% |
526,230
-7,276
| -1% | -$606K |
2013 Q2
7 quarters
|
|
38
Honeywell
HON
$67.9B
| $43.9M | 1.17% |
468,426
-17,813
| -4% | -$1.63M |
2013 Q2
7 quarters
|
|
|
39
Adobe
ADBE
$94.9B
| $43.9M | 1.17% |
593,640
+484,118
| +442% | +$36.1M |
2013 Q4
5 quarters
|
|
40
HP
HPQ
$28.4B
| $43.5M | 1.16% |
3,075,837
-1,760,907
| -36% | -$29.1M |
2014 Q2
3 quarters
|
|
41
Oracle
ORCL
$432B
| $42.8M | 1.14% |
992,474
+96,469
| +11% | +$4.18M |
2014 Q4
1 quarter
|
|
|
SCHW
42
Charles Schwab
SCHW
$169B
| $42.8M | 1.14% |
1,406,291
-1,321,641
| -48% | -$38.3M |
2013 Q2
7 quarters
|
|
|
MRSH
43
Marsh
MRSH
$81.3B
| $40.9M | 1.09% |
728,920
-40,229
| -5% | -$2.27M |
2013 Q2
7 quarters
|
|
44
T-Mobile US
TMUS
$177B
| $40.8M | 1.09% |
1,287,666
-93,795
| -7% | -$2.92M |
2014 Q4
1 quarter
|
|
45
Thermo Fisher Scientific
TMO
$250B
| $39.9M | 1.06% |
296,760
-16,335
| -5% | -$2.11M |
2014 Q3
2 quarters
|
|
|
46
Microsoft
MSFT
$3.9T
| $39M | 1.04% |
960,069
-1,804,372
| -65% | -$78.6M |
2013 Q2
7 quarters
|
|
47
Micron Technology
MU
$1.2T
| $38.4M | 1.02% |
1,414,845
-1,000,102
| -41% | -$29.9M |
2014 Q2
3 quarters
|
|
48
Teva Pharmaceutical Industries Limited
TEVA
$46.3B
| $38M | 1.01% |
609,503
-43,423
| -7% | -$2.52M |
2014 Q4
1 quarter
|
|
49
TE Connectivity
TEL
$63.4B
| $22.9M | 0.61% |
319,475
-283,576
| -47% | -$19.5M |
2013 Q3
6 quarters
|
|
50
Altria Group
MO
$113B
| $20.8M | 0.55% |
415,368
+376,699
| +974% | +$20M |
2013 Q2
7 quarters
|
|
Similar funds
SPPAM
BCM
CIA
JCM
ECM
BPWM
KKRC
DSC
Atalanta Sosnoff Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Atalanta Sosnoff Capital held 109 positions worth $3.75B, down 7.4% from $4.05B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Atalanta Sosnoff Capital withdrew a net $320M in Q1 2015, closing 8 positions and reducing 50 holdings. Its most notable exit was Ralph Lauren, an estimated $41.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Atalanta Sosnoff Capital opened a new position in Boston Scientific worth $50M.
- Atalanta Sosnoff Capital's largest Q1 2015 buy was Boston Scientific: 2,819,545 shares worth $50M.
- Atalanta Sosnoff Capital added most to Allergan plc in Q1 2015, an estimated $46M increase.
- Atalanta Sosnoff Capital's biggest Q1 2015 reduction was Microsoft, cutting an estimated $78.6M.
- Atalanta Sosnoff Capital fully exited Ralph Lauren in Q1 2015, selling an estimated $41.5M.
- Atalanta Sosnoff Capital's ten largest holdings make up 33% of its $3.75B portfolio in Q1 2015.
- Atalanta Sosnoff Capital opened 13 new positions and closed 8 in Q1 2015.
- Atalanta Sosnoff Capital's portfolio value fell 7.4% quarter-over-quarter to $3.75B.
Based on Atalanta Sosnoff Capital's 13F filing for Q1 2015, filed 9 Apr 2015.